Thomas Dierks
Bielefeld, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
New structures of human formylglycine-generating enzyme reveal features important for catalysis, disease and structure-based drug design.
Journal: Journal of molecular biology
Published: February 18, 2026
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency.
Journal: EMBO molecular medicine
Published: July 12, 2021
Arylsulfatase K inactivation causes mucopolysaccharidosis due to deficient glucuronate desulfation of heparan and chondroitin sulfate.
Journal: The Biochemical journal
Published: July 09, 2020
Bifunctional Reagents for Formylglycine Conjugation: Pitfalls and Breakthroughs.
Journal: Chembiochem : a European journal of chemical biology
Published: June 29, 2020
Natural history of multiple sulfatase deficiency: Retrospective phenotyping and functional variant analysis to characterize an ultra-rare disease.
Journal: Journal of inherited metabolic disease
Published: March 31, 2020
Heparan Sulfate-Editing Extracellular Sulfatases Enhance VEGF Bioavailability for Ischemic Heart Repair.
Journal: Circulation research
Published: August 23, 2019
A homozygous missense variant of SUMF1 in the Bedouin population extends the clinical spectrum in ultrarare neonatal multiple sulfatase deficiency.
Journal: Molecular genetics & genomic medicine
Published: August 22, 2019
Conversion of Serine-Type Aldehyde Tags by the Radical SAM Protein AtsB from Methanosarcina mazei.
Journal: Chembiochem : a European journal of chemical biology
Published: May 14, 2019
Expression, characterization, and site-specific covalent immobilization of an L-amino acid oxidase from the fungus Hebeloma cylindrosporum.
Journal: Applied microbiology and biotechnology
Published: August 27, 2018
Last Updated: 09/26/2026